Pharma sector struggling with data, AspenTech survey finds

Almost half of the pharmaceutical companies surveyed by AspenTech struggle with data insights

Nearly half of European and US pharmaceutical companies have admitted their competitiveness is suffering because they cannot use data insights, new research from AspenTech has found. 

The study polled 300 senior decision makers within the industry in the UK, US, Germany, France, Spain and Sweden. The research found a widespread lack of predictive capabilities within the industry, with almost half (49%) of respondents saying their companies are not good enough at predicting demand for a product and adjusting output to match it. 

The results suggest that poor digital capabilities are holding companies back, affecting business performance. Other key findings include: 


  • 49% of pharmaceutical companies struggle to use data effectively to improve time to market
  • 49% are not good enough at predicting demand for a product and adjusting output to match it
  • 48% rate their organisation as either poor or ineffective at using data to predict and resolve supply shortages

“This should sound an alarm bell within the pharmaceutical industry,” said David Leitham, Senior Vice President and General Manager, Pharma at AspenTech. “Leading organisations stand out for their ability to use data effectively across all aspects of drug manufacture. Data-driven organisations are faster to innovate and respond to opportunities or threats at speed.

“Pharma manufacturers have traditionally been moving slowly and incrementally towards ‘Pharma 4.0" he added. “For more than half of all organisations this needs to accelerate if they are to avoid falling further behind.”


Featured Articles

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Three months on, the cyberattack on UnitedHealth Group's Change Healthcare is still affecting US citizens, with delays and

McKinsey: National E-health Initiatives on the Rise

McKinsey report on countries that are scaling national e-health programmes says it is easing financial pressures on healthcare systems globally

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma

London Hospitals Cyberattack Wreaks Healthcare Havoc

Technology & AI

Healthcare Provision in India: Challenges and Opportunities

Health Insurance & Finance